• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Advances in migraine treatment.

作者信息

Nissan George R, Diamond Merle L

机构信息

Diamond Headache Clinic, 467 W Deming Pl, Suite 500, Chicago, IL 60614-2970, USA.

出版信息

J Am Osteopath Assoc. 2005 Apr;105(4 Suppl 2):9S-15S.

PMID:15928348
Abstract

Migraine is a common, incapacitating disorder that is underdiagnosed in clinical practice. Early and correct diagnosis of migraine is essential and can lead to significant improvements in a patient's quality of life. In the clinical practice setting, a screening tool can be used that can help differentiate migraine from other headache disorders. New research into the development of central sensitization and cutaneous allodynia in chronic migraine sufferers has led to an early treatment approach with triptans and other agents for acute migraine episodes. This approach results in greater 2-hour headache pain-free results. The use of botulinum toxin type A in the prophylaxis of migraine and mixed-headache types offers an alternative treatment in patients who may not have responded to other currently available migraine prophylactic agents.

摘要

相似文献

1
Advances in migraine treatment.
J Am Osteopath Assoc. 2005 Apr;105(4 Suppl 2):9S-15S.
2
Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.A型肉毒杆菌毒素用于因依从性问题而导致口服预防性治疗失败的偏头痛患者的预防性治疗。
Headache. 2008 Jun;48(6):900-13. doi: 10.1111/j.1526-4610.2007.00953.x. Epub 2007 Nov 28.
3
Botulinum toxin type A in chronic migraine.
Expert Rev Neurother. 2007 May;7(5):463-70. doi: 10.1586/14737175.7.5.463.
4
Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.A型肉毒杆菌毒素预防性治疗发作性偏头痛:一项随机、双盲、安慰剂对照的探索性研究。
Headache. 2007 Apr;47(4):486-99. doi: 10.1111/j.1526-4610.2006.00624.x.
5
Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.A型肉毒杆菌毒素治疗无药物过度使用的慢性偏头痛。
Headache. 2008 Feb;48(2):201-9. doi: 10.1111/j.1526-4610.2007.00963.x. Epub 2007 Nov 28.
6
Migraine treatment throughout the lifecycle.偏头痛在整个生命周期中的治疗。
Expert Rev Neurother. 2005 May;5(3):343-53. doi: 10.1586/14737175.5.3.343.
7
Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.A型肉毒杆菌毒素与丙戊酸二钠用于发作性或慢性偏头痛的预防性治疗。
Headache. 2008 Feb;48(2):210-20. doi: 10.1111/j.1526-4610.2007.00949.x. Epub 2007 Nov 28.
8
Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients.A型肉毒杆菌毒素预防性治疗对偏头痛患者急性头痛药物使用的影响。
Curr Med Res Opin. 2004 Jan;20(1):49-53. doi: 10.1185/030079903125002676.
9
Botulinum toxin type A in prophylactic treatment of migraine.A型肉毒杆菌毒素用于偏头痛的预防性治疗。
Am J Ther. 2006 May-Jun;13(3):183-7. doi: 10.1097/01.mjt.0000212705.79248.74.
10
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).疼痛强度和给药时间对阿莫曲坦反应性的影响:来自AXERT 12.5毫克时间与强度偏头痛研究(AIMS)的结果。
Headache. 2007 Apr;47(4):519-30. doi: 10.1111/j.1526-4610.2007.00756.x.

引用本文的文献

1
Practical considerations for the treatment of elderly patients with migraine.老年偏头痛患者治疗的实际考量
Drugs Aging. 2006;23(6):461-89. doi: 10.2165/00002512-200623060-00003.
2
Sumatriptan fast-disintegrating/rapid-release tablets.舒马曲坦口腔崩解/速释片
Drugs. 2006;66(6):883-90. doi: 10.2165/00003495-200666060-00018.